全球UNITE-COVID研究:COVID-19第一波高峰期间与死亡率相关的临床和组织因素
该全球多中心、国际性、时点患病率研究纳入2020年2月15日至5月15日期间ICU收治的经PCR确诊SARS-CoV-2感染的成人COVID-19患者,共46个国家280个ICU的4994例患者。ICU总床位从4931张增至7630张,1986例(39.8%)患者收治于扩容床位;入ICU时有创通气2325例(46.5%),ICU期间需有创通气者占85.8%。60天死亡率为33.9%(各单元间IQR 20%-50%),ICU死亡率为32.7%;高龄、有创机械通气和急性肾损伤与死亡率增加相关,这些关联在机械通气患者中亦得到证实;收治于扩容床位与死亡率无关,即使控制其他因素后亦然。
要点
- 全球46个国家280个ICU共纳入4994例COVID-19成人患者,ICU总床位从4931张扩至7630张,1986例(39.8%)收治于扩容床位。
- 入ICU时有创通气2325例(46.5%),ICU期间需有创通气者占85.8%。
- 60天死亡率为33.9%(各单元间IQR 20%-50%),ICU死亡率为32.7%。
- 高龄、有创机械通气和急性肾损伤与死亡率增加相关,且在机械通气患者中亦得到证实。
- 收治于扩容床位与死亡率无关,即使控制其他因素后亦然。
适用人群与场景
- 2020年2月15日至5月15日期间ICU收治的经PCR确诊SARS-CoV-2感染的成人COVID-19患者。
研究设计与关键结果
- 研究类型:多中心、国际性、时点患病率研究;样本量:4994例患者,来自46个国家280个ICU。
- 纳入ICU的总床位从4931张增至7630张,并从其他区域调配人员;1986例(39.8%)患者收治于扩容床位。
- 入ICU时有创通气2325例(46.5%),ICU期间需有创通气者占85.8%。
- 60天死亡率为33.9%(各单元间IQR 20%-50%),ICU死亡率为32.7%。
- 高龄、有创机械通气和急性肾损伤与死亡率增加相关;这些关联在机械通气患者中亦得到证实。
- 收治于扩容床位与死亡率无关,即使控制其他因素后亦然。
证据类型、等级与局限
- 证据类型:多中心、国际性、时点患病率研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 研究提示ICU可通过增加床位和人员应对COVID-19患者增加,至多40%患者收治于扩容床位。
- 收治于扩容床位与死亡率增加无关,即使控制其他因素后亦然。
- 高龄、有创机械通气和急性肾损伤被确定为最强的死亡预测因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To accommodate the unprecedented number of critically ill patients with pneumonia caused by coronavirus disease 2019 (COVID-19) expansion of the capacity of intensive care unit (ICU) to clinical areas not previously used for critical care was necessary. We describe the global burden of COVID-19 admissions and the clinical and organizational characteristics associated with outcomes in critically ill COVID-19 patients.
METHODS: Multicenter, international, point prevalence study, including adult patients with SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) and a diagnosis of COVID-19 admitted to ICU between February 15th and May 15th, 2020.
RESULTS: 4994 patients from 280 ICUs in 46 countries were included. Included ICUs increased their total capacity from 4931 to 7630 beds, deploying personnel from other areas. Overall, 1986 (39.8%) patients were admitted to surge capacity beds. Invasive ventilation at admission was present in 2325 (46.5%) patients and was required during ICU stay in 85.8% of patients. 60-day mortality was 33.9% (IQR across units: 20%-50%) and ICU mortality 32.7%. Older age, invasive mechanical ventilation, and acute kidney injury (AKI) were associated with increased mortality. These associations were also confirmed specifically in mechanically ventilated patients. Admission to surge capacity beds was not associated with mortality, even after controlling for other factors.
CONCLUSIONS: ICUs responded to the increase in COVID-19 patients by increasing bed availability and staff, admitting up to 40% of patients in surge capacity beds. Although mortality in this population was high, admission to a surge capacity bed was not associated with increased mortality. Older age, invasive mechanical ventilation, and AKI were identified as the strongest predictors of mortality.
参考来源
- Greco M, De Corte T, Ercole A, et al. Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study. Intensive Care Med. 2022. PMID: 35596752. doi:10.1007/s00134-022-06705-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。